23 May 2013
Keywords: osi, 55m, deal, sell, serono, novantrone, pharmaceuticals
Article | 17 March 2003
OSI Pharmaceuticals has entered into an agreement to market Serono'santicancer drug Novantrone (mitoxantrone concentrate for injection) in
the USA in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2003
10 March 2003
24 March 2003
© 2013 thepharmaletter.com